share_log

Truist Securities Maintains Buy on Autolus Therapeutics, Raises Price Target to $11

Truist Securities Maintains Buy on Autolus Therapeutics, Raises Price Target to $11

Truist Securities維持對Autolus Therapeutics的買入,將目標股價上調至11美元
Moomoo 24/7 ·  04/09 13:41

Truist Securities analyst Gil Blum maintains Autolus Therapeutics (NASDAQ:AUTL) with a Buy and raises the price target from $10 to $11.

Truist Securities分析師吉爾·布魯姆維持Autolus Therapeutics(納斯達克股票代碼:AUTL)的買入並將目標股價從10美元上調至11美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論